newsfilter
← Latest News
GlobeNewswire·

Editas Medicine to Participate in Upcoming Investor Conferences

CAMBRIDGE, Mass., Feb. 23, 2026 (GLOBE NEWSWIRE) -- Editas Medicine, Inc. (NASDAQ:EDIT), a pioneering gene editing company focused on developing transformative medicines for serious diseases, today announced that